-
International Journal of Nephrology and Renovascular Disease
- About Dovepress
Open access peer-reviewed scientific and medical journals.
- Open Access
Dove Medical Press is now a member of the Open Access Initiative
- An Author's Guide
A guide to help authors get their paper published.
- Advocacy
Support Open Access and Dove Press
- Reprints
Promotional Article Monitoring - further details
- Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Update on the diagnosis and management of acute kidney injury
Review
(11336) Total Article Views
Authors: Ali Akcay, Kultigin Turkmen, DongWon Lee, et al
Published Date September 2010 Volume 2010:3 Pages 129 - 140
DOI: http://dx.doi.org/10.2147/IJNRD.S8641
Ali Akcay, Kultigin Turkmen, DongWon Lee, Charles L EdelsteinDivision of Renal Diseases and Hypertension, University of Colorado and the Health Sciences Center, Aurora, Colorado, USA
Abstract: Acute kidney injury (AKI) is an independent risk factor for morbidity and mortality. This review provides essential information for the diagnosis and management of AKI. Blood urea nitrogen and serum creatinine are used for the diagnosis of AKI. The review also focuses on recent studies on the diagnosis of AKI using the RIFLE (R-renal risk, I-injury, F-failure, L-loss of kidney function, E-end stage kidney disease) and Acute Kidney Injury Network criteria, and serum and urine AKI biomarkers. Dialysis is the only Food and Drug Administration-approved therapy for AKI. Recent studies on the dose of dialysis in AKI are reviewed.
Keywords: acute kidney injury, biomarkers, interleukin-18
Post to:
Cannotea Citeulike Del.icio.us Facebook LinkedIn Twitter
Readers of this article also read:
- Call For Submissions
Submit Original Research Article, Review, Case Report, or Rapid Communication in International Journal of Nephrology and Renovascular Disease
- Functional evaluation of the urinary tract by duplex Doppler ultrasonography in patients with acute renal colic
- Potential renovascular hypertension, space missions, and the role of magnesium
- Treatment of secondary hyperparathyroidism in kidney disease: what we know and do not know about use of calcimimetics and vitamin D analogs
- The use of everolimus in renal-transplant patients